Department of ENT, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Am J Otolaryngol. 2011 Sep-Oct;32(5):402-7. doi: 10.1016/j.amjoto.2010.07.019. Epub 2010 Oct 13.
Allergic rhinitis is the most common chronic and allergic disease, especially in children. This study aimed to investigate the anti-inflammatory effects of Nigella sativa and its effects on inflammatory factors in patients with allergic rhinitis symptoms and the process their clinical study charges.
The present study is a clinical trial that conducted as prospective and double blind with descriptive analytic.
The sample included 66 patients (case and placebo) with allergic rhinitis exposed to N. sativa oil. Individual characteristics, including age and sex, and characteristics of the disease, including nasal congestion, runny nose, itchy nose, and sneezing attacks, were evaluated. From the start of the study, that is, day 0, up to the end of the study, that is, day 30, an observer completed the symptoms severity questionnaire.
Data were presented as means ± SEM. Comparisons between groups were performed by using paired Student t test. Differences were considered significant if P values are less than .05 and .01.
In the present study, 66 patients with allergic rhinitis, including 22 males (33.3%) and 44 females (66.7%) with a mean age of 47.19 years, were included. Immunoglobulin E total of more than 100 was reported in 38 patients before treatment. Immunoglobulin E in nasal wash from 7 patients was observed and was not measurable in 59 cases. Only 6.1% of the study population had nasal mucosal eosinophil.
The results show that N. sativa could reduce the presence of the nasal mucosal congestion, nasal itching, runny nose, sneezing attacks, turbinate hypertrophy, and mucosal pallor during the first 2 weeks (day 15). The present findings are consistent with evidence that the antiallergic effects of N. sativa components could be attributed to allergic rhinitis. Moreover, N. sativa should be considered for treating allergic rhinitis when the effects of other antiallergic drugs need to be avoided.
过敏性鼻炎是最常见的慢性过敏性疾病,尤其在儿童中较为常见。本研究旨在探讨黑种草子的抗炎作用及其对过敏性鼻炎症状患者炎症因子的影响,并对其临床研究费用进行研究。
本研究为前瞻性、双盲、描述性分析的临床试验。
样本包括 66 例(病例组和安慰剂组)暴露于黑种草子油的过敏性鼻炎患者。评估个体特征,包括年龄和性别,以及疾病特征,包括鼻塞、流涕、鼻痒和打喷嚏发作。从研究开始,即第 0 天,到研究结束,即第 30 天,观察者完成症状严重程度问卷。
数据表示为均数±SEM。组间比较采用配对学生 t 检验。如果 P 值小于 0.05 和 0.01,则认为差异具有统计学意义。
本研究共纳入 66 例过敏性鼻炎患者,其中男性 22 例(33.3%),女性 44 例(66.7%),平均年龄为 47.19 岁。治疗前,38 例患者的总免疫球蛋白 E 超过 100,7 例患者的鼻冲洗免疫球蛋白 E 可检测,59 例患者不可检测。研究人群中仅有 6.1%的患者存在鼻黏膜嗜酸性粒细胞。
结果表明,黑种草子在治疗的前 2 周(第 15 天)可减轻鼻黏膜充血、鼻痒、流涕、打喷嚏、鼻甲肥大和黏膜苍白等症状。本研究结果与黑种草子成分的抗过敏作用可能归因于过敏性鼻炎的证据一致。此外,当需要避免使用其他抗过敏药物时,应考虑使用黑种草子治疗过敏性鼻炎。